# Phase I, Open Label Dose Ranging Safety Study of GLS-5300 in Healthy Volunteers

> **NCT02670187** · PHASE1 · COMPLETED · sponsor: **GeneOne Life Science, Inc.** · enrollment: 75 (actual)

## Conditions studied

- Healthy

## Interventions

- **BIOLOGICAL:** GLS-5300

## Key facts

- **NCT ID:** NCT02670187
- **Lead sponsor:** GeneOne Life Science, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02
- **Primary completion:** 2017-05
- **Final completion:** 2017-09
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2019-01-09

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02670187

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02670187, "Phase I, Open Label Dose Ranging Safety Study of GLS-5300 in Healthy Volunteers". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02670187. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*